Research, correspondence, and publications from Equity Risk Sciences documenting the standard of care for investment fiduciaries.
The Scientific Standard of Demonstrable Evidence for Investment Fiduciaries. A regulatory white paper documenting the gap between the standard the SEC has articulated and the standard the industry actually practices — and proposing that the gap be closed using data science tools that exist today.
A formal proposal to the Securities and Exchange Commission presenting ten concrete reforms to enhance the regulatory framework governing Registered Investment Advisors — including mandatory risk disclosure, bond-alternative analysis, and professional track record requirements — supported by 11 exhibits documenting 25 years of evidence.
In May 2020, Forbes asked ERS founder Raymond Mullaney to name one high-risk and one low-risk stock. He identified Bristol-Myers as high risk and BorgWarner as low risk. One year later, BorgWarner was up 58%, the S&P 500 was up 38%, and Bristol-Myers was up just 9%.
In 2000, Raymond Mullaney contacted the Securities and Exchange Commission to raise concerns about potentially misleading earnings presentations by General Electric and Cisco Systems. Within two years of the correspondence, Cisco lost 83% of its value and GE lost 62% — erasing over two-thirds of a trillion dollars in combined market capitalization.
Report downloads and detailed content are available to authorized users. If you already have credentials, log in below. Otherwise, request access and we will review your request promptly.